Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Phosphatase 1 | 10 | 2022 | 58 | 2.180 |
Why?
|
| Virus Replication | 10 | 2019 | 261 | 1.510 |
Why?
|
| HIV-1 | 9 | 2022 | 678 | 1.240 |
Why?
|
| Ebolavirus | 4 | 2019 | 42 | 1.120 |
Why?
|
| Transcription, Genetic | 8 | 2022 | 550 | 1.000 |
Why?
|
| Cyclin-Dependent Kinase 9 | 4 | 2018 | 37 | 0.930 |
Why?
|
| Antiviral Agents | 3 | 2018 | 148 | 0.760 |
Why?
|
| Serine | 3 | 2018 | 72 | 0.580 |
Why?
|
| Polycythemia | 5 | 2017 | 15 | 0.540 |
Why?
|
| Phosphorylation | 11 | 2022 | 878 | 0.540 |
Why?
|
| Anti-HIV Agents | 3 | 2015 | 394 | 0.500 |
Why?
|
| Anemia, Sickle Cell | 4 | 2021 | 169 | 0.490 |
Why?
|
| RNA-Binding Proteins | 3 | 2012 | 145 | 0.470 |
Why?
|
| Gene Expression Regulation, Viral | 4 | 2019 | 108 | 0.460 |
Why?
|
| Biocatalysis | 1 | 2012 | 27 | 0.440 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 43 | 0.420 |
Why?
|
| Endoribonucleases | 1 | 2010 | 23 | 0.390 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2010 | 42 | 0.380 |
Why?
|
| Viral Proteins | 5 | 2019 | 172 | 0.380 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 3 | 2018 | 52 | 0.350 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 5 | 2017 | 19 | 0.340 |
Why?
|
| RNA, Viral | 6 | 2019 | 287 | 0.310 |
Why?
|
| Erythropoietin | 4 | 2016 | 37 | 0.280 |
Why?
|
| Transcription Factors | 3 | 2019 | 653 | 0.240 |
Why?
|
| Hydroxyurea | 2 | 2016 | 34 | 0.230 |
Why?
|
| Cell Line | 5 | 2019 | 1289 | 0.230 |
Why?
|
| Humans | 24 | 2022 | 34853 | 0.220 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2012 | 184 | 0.210 |
Why?
|
| Sickle Cell Trait | 1 | 2021 | 18 | 0.210 |
Why?
|
| Amino Acid Sequence | 3 | 2018 | 1124 | 0.200 |
Why?
|
| Drug Stability | 2 | 2018 | 110 | 0.200 |
Why?
|
| Vero Cells | 5 | 2019 | 90 | 0.200 |
Why?
|
| Catalytic Domain | 2 | 2018 | 97 | 0.190 |
Why?
|
| Protein Binding | 5 | 2018 | 913 | 0.190 |
Why?
|
| Urea | 2 | 2019 | 42 | 0.180 |
Why?
|
| Viral Core Proteins | 1 | 2019 | 10 | 0.180 |
Why?
|
| Nucleoproteins | 1 | 2019 | 10 | 0.180 |
Why?
|
| Lymphopenia | 1 | 2019 | 15 | 0.180 |
Why?
|
| Mass Spectrometry | 2 | 2011 | 255 | 0.180 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2019 | 29 | 0.180 |
Why?
|
| Animals | 9 | 2022 | 14307 | 0.170 |
Why?
|
| Encephalitis Virus, Venezuelan Equine | 1 | 2018 | 9 | 0.170 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2017 | 81 | 0.170 |
Why?
|
| Indoles | 2 | 2019 | 154 | 0.170 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 1490 | 0.170 |
Why?
|
| Capsid | 1 | 2018 | 51 | 0.160 |
Why?
|
| Capsid Proteins | 1 | 2018 | 60 | 0.160 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 251 | 0.160 |
Why?
|
| Cyclin-Dependent Kinase 2 | 2 | 2018 | 30 | 0.150 |
Why?
|
| Cytochrome-B(5) Reductase | 1 | 2017 | 3 | 0.150 |
Why?
|
| Methemoglobinemia | 1 | 2017 | 2 | 0.150 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2016 | 2 | 0.150 |
Why?
|
| Thrombospondin 1 | 1 | 2017 | 22 | 0.150 |
Why?
|
| Thrombosis | 1 | 2017 | 61 | 0.140 |
Why?
|
| HIV Infections | 2 | 2021 | 2207 | 0.140 |
Why?
|
| Rift Valley fever virus | 1 | 2016 | 6 | 0.140 |
Why?
|
| Cells, Cultured | 3 | 2018 | 1442 | 0.140 |
Why?
|
| Germ-Line Mutation | 2 | 2017 | 51 | 0.140 |
Why?
|
| Models, Molecular | 3 | 2018 | 751 | 0.140 |
Why?
|
| T-Lymphocytes | 2 | 2015 | 341 | 0.140 |
Why?
|
| Homozygote | 3 | 2013 | 75 | 0.130 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2015 | 55 | 0.130 |
Why?
|
| Leukocytes, Mononuclear | 4 | 2021 | 224 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2013 | 79 | 0.130 |
Why?
|
| DNA Replication | 1 | 2016 | 148 | 0.130 |
Why?
|
| Curcumin | 1 | 2015 | 66 | 0.130 |
Why?
|
| Antisickling Agents | 2 | 2016 | 15 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2014 | 11 | 0.120 |
Why?
|
| Streptomycin | 1 | 2013 | 4 | 0.120 |
Why?
|
| Mice | 3 | 2022 | 5668 | 0.120 |
Why?
|
| Mutation | 3 | 2018 | 1023 | 0.120 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 968 | 0.120 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2013 | 30 | 0.120 |
Why?
|
| Gene Expression | 1 | 2017 | 639 | 0.120 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2013 | 20 | 0.120 |
Why?
|
| Enzyme Activation | 2 | 2012 | 423 | 0.120 |
Why?
|
| Nuclear Proteins | 2 | 2012 | 287 | 0.110 |
Why?
|
| Hypertension, Pulmonary | 1 | 2014 | 77 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 638 | 0.110 |
Why?
|
| Intracellular Space | 1 | 2012 | 35 | 0.110 |
Why?
|
| Amino Acid Motifs | 1 | 2012 | 85 | 0.110 |
Why?
|
| Host-Pathogen Interactions | 3 | 2019 | 179 | 0.110 |
Why?
|
| Iron | 1 | 2013 | 204 | 0.100 |
Why?
|
| DNA-Binding Proteins | 2 | 2012 | 522 | 0.100 |
Why?
|
| Peptide Mapping | 1 | 2011 | 19 | 0.100 |
Why?
|
| Protein Transport | 1 | 2012 | 286 | 0.100 |
Why?
|
| Point Mutation | 2 | 2009 | 88 | 0.100 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2011 | 33 | 0.100 |
Why?
|
| Threonine | 1 | 2010 | 21 | 0.100 |
Why?
|
| Gene Products, tat | 1 | 2010 | 34 | 0.100 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 195 | 0.100 |
Why?
|
| RNA Polymerase II | 1 | 2010 | 24 | 0.100 |
Why?
|
| Binding Sites | 1 | 2012 | 597 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 355 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2012 | 351 | 0.090 |
Why?
|
| Rabbits | 1 | 2010 | 278 | 0.090 |
Why?
|
| Fetal Hemoglobin | 1 | 2009 | 13 | 0.090 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2009 | 13 | 0.090 |
Why?
|
| Peptides | 1 | 2012 | 308 | 0.090 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 520 | 0.090 |
Why?
|
| CDC2 Protein Kinase | 1 | 2008 | 17 | 0.080 |
Why?
|
| RNA Splicing | 1 | 2008 | 36 | 0.080 |
Why?
|
| RNA, Messenger | 2 | 2014 | 1152 | 0.080 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2008 | 11 | 0.080 |
Why?
|
| Homocysteine | 1 | 2008 | 18 | 0.080 |
Why?
|
| Dipeptides | 1 | 2008 | 29 | 0.080 |
Why?
|
| Glutathione | 1 | 2008 | 160 | 0.080 |
Why?
|
| Female | 9 | 2021 | 19873 | 0.070 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 391 | 0.070 |
Why?
|
| RNA Interference | 2 | 2019 | 225 | 0.070 |
Why?
|
| Cytokines | 1 | 2009 | 569 | 0.070 |
Why?
|
| Protein Conformation | 2 | 2018 | 350 | 0.060 |
Why?
|
| Male | 8 | 2017 | 18870 | 0.060 |
Why?
|
| PPAR alpha | 1 | 2022 | 42 | 0.050 |
Why?
|
| Cell Hypoxia | 2 | 2014 | 55 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2017 | 1056 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 183 | 0.050 |
Why?
|
| Russia | 2 | 2011 | 24 | 0.050 |
Why?
|
| Child | 3 | 2017 | 2875 | 0.050 |
Why?
|
| Adult | 5 | 2017 | 11034 | 0.050 |
Why?
|
| Nucleocapsid Proteins | 1 | 2019 | 9 | 0.050 |
Why?
|
| Antigens, Viral | 1 | 2019 | 42 | 0.050 |
Why?
|
| Jurkat Cells | 1 | 2019 | 72 | 0.050 |
Why?
|
| Ribonucleoproteins | 1 | 2019 | 29 | 0.050 |
Why?
|
| Viral Matrix Proteins | 1 | 2019 | 17 | 0.050 |
Why?
|
| Chiroptera | 1 | 2019 | 20 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2017 | 1318 | 0.040 |
Why?
|
| Virion | 1 | 2019 | 67 | 0.040 |
Why?
|
| Immunoprecipitation | 2 | 2010 | 126 | 0.040 |
Why?
|
| Viral Envelope Proteins | 1 | 2019 | 77 | 0.040 |
Why?
|
| Cyclin T | 1 | 2018 | 16 | 0.040 |
Why?
|
| Autophagy | 1 | 2019 | 111 | 0.040 |
Why?
|
| eIF-2 Kinase | 1 | 2018 | 14 | 0.040 |
Why?
|
| Hela Cells | 2 | 2010 | 344 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2018 | 54 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 161 | 0.040 |
Why?
|
| Adolescent | 3 | 2017 | 5035 | 0.040 |
Why?
|
| Methemoglobin | 1 | 2017 | 3 | 0.040 |
Why?
|
| Erythrocyte Count | 1 | 2017 | 11 | 0.040 |
Why?
|
| Proteomics | 1 | 2019 | 302 | 0.040 |
Why?
|
| Siberia | 1 | 2017 | 4 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2017 | 82 | 0.040 |
Why?
|
| Hemoglobins | 1 | 2017 | 101 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 102 | 0.040 |
Why?
|
| Rift Valley Fever | 1 | 2016 | 5 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 2015 | 48 | 0.030 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2015 | 33 | 0.030 |
Why?
|
| Heme Oxygenase-1 | 1 | 2015 | 46 | 0.030 |
Why?
|
| Half-Life | 1 | 2015 | 52 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 423 | 0.030 |
Why?
|
| Genome, Viral | 1 | 2016 | 103 | 0.030 |
Why?
|
| Virulence | 1 | 2016 | 221 | 0.030 |
Why?
|
| Models, Biological | 1 | 2018 | 642 | 0.030 |
Why?
|
| Middle Aged | 3 | 2017 | 9642 | 0.030 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2014 | 25 | 0.030 |
Why?
|
| Prognosis | 1 | 2017 | 707 | 0.030 |
Why?
|
| Transfection | 1 | 2015 | 496 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 964 | 0.030 |
Why?
|
| Incidence | 1 | 2017 | 882 | 0.030 |
Why?
|
| Phlebotomy | 1 | 2013 | 4 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2017 | 727 | 0.030 |
Why?
|
| Streptomyces | 1 | 2013 | 18 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2014 | 68 | 0.030 |
Why?
|
| Protein Stability | 1 | 2013 | 40 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 859 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 1014 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2013 | 78 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 160 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2013 | 203 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 600 | 0.030 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2012 | 12 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2013 | 135 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 984 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 485 | 0.030 |
Why?
|
| Kinetics | 1 | 2013 | 650 | 0.030 |
Why?
|
| Prevalence | 1 | 2017 | 1425 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2012 | 143 | 0.030 |
Why?
|
| Insulin | 1 | 2013 | 224 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 406 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2013 | 333 | 0.030 |
Why?
|
| Ferritins | 1 | 2011 | 54 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2017 | 1961 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2013 | 436 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2010 | 48 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 2333 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 1422 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 1353 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 383 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 420 | 0.020 |
Why?
|
| Inflammation | 1 | 2014 | 577 | 0.020 |
Why?
|
| CD4-CD8 Ratio | 1 | 2009 | 28 | 0.020 |
Why?
|
| Young Adult | 2 | 2009 | 4012 | 0.020 |
Why?
|
| Interleukins | 1 | 2009 | 28 | 0.020 |
Why?
|
| Exons | 1 | 2009 | 80 | 0.020 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2008 | 9 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 157 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 325 | 0.020 |
Why?
|
| Genotype | 1 | 2009 | 641 | 0.020 |
Why?
|
| Apoptosis | 1 | 2014 | 1317 | 0.020 |
Why?
|
| Aged | 1 | 2017 | 6448 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2013 | 1802 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2008 | 613 | 0.020 |
Why?
|